Andersson A, Toppari J, Haavisto A, Petersen JH, Simell T, Simell O, Skakkebk NE (1998) Longitudinal Reproductive Hormone Profiles in Infants: Peak of Inhibin B Levels in Infant Boys Exceeds Levels in Adult Men1
This cessation symptom leads to another common post-treatment effect: weight gain
Victoza (liraglutide), the first GLP-1 for type 2 diabetes to lose exclusivity in June 2024, may not generate significant savings due to its once-daily dosing and limited market share
WADA-banned peptides (for athletes): These aren't illegal for general population but banned in competitive sports: TB-500 BPC-157 Growth hormone releasing peptides (GHRP-6, GHRP-2, Ipamorelin) CJC-1295 IGF-1 variants If you're a competitive athlete: Using these can result in bans, not criminal charges (unless you're distributing)
Within scientific research, this peptide has received considerable attention in recent years because of its potential role in repair processes, tissue regeneration and support of various biological systems
Since compounding pharmacies are regulated by state boards rather than the FDA, they can produce BPC-157 despite its unapproved status and associated quality control concerns